Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine

Introduction: Proton Pump inhibitors (PPIs) are commonly used for a variety of acid related disorders. Despite the overall effectiveness and safety profile of PPIs, some patients do not respond adequately or develop treatment related adverse events. This variable response among patients is in part d...

Descripción completa

Detalles Bibliográficos
Autores principales: El Rouby, Nihal, Lima, John J., Johnson, Julie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942154/
https://www.ncbi.nlm.nih.gov/pubmed/29620484
http://dx.doi.org/10.1080/17425255.2018.1461835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942154/
https://www.ncbi.nlm.nih.gov/pubmed/29620484
http://dx.doi.org/10.1080/17425255.2018.1461835

Ejemplares similares